K‐RasV14I‐induced Noonan syndrome predisposes to tumour development in mice

Cancer statistics, 2013

Siegel, R., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21166 · Cited by 11,825 · see citing works

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649 · see citing works

Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice

Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609 · see citing works

Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse

Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471 · see citing works

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

Forbes, S. A., Bindal, N., Bamford, S., Cole, C., Kok, C. Y., Beare, D., Jia, M., Shepherd, R., Leung, K., Menzies, A., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq929 · Cited by 2,278 · see citing works

Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes

Almoguera, C., Shibata, D. K., Forrester, K., Wj, M., Arnheim, N., & Perucho, M. (1988) · Cell · doi:10.1016/0092-8674(88)90571-5 · Cited by 2,100 · see citing works

Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-rasPreprint

Jackson, E. L., Willis, N. A., Mercer, K. L., Bronson, R. T., Crowley, D. G., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,877 · see citing works

Role of the INK4a Locus in Tumor Suppression and Cell Mortality

Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585 · see citing works

Hyperactive Ras in developmental disorders and cancer

Schubbert, S., Shannon, K., & Bollag, G. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2109 · Cited by 1,583 · see citing works

Genetics and biology of pancreatic ductal adenocarcinomaPreprint

Hezel, A. F., Kimmelman, A. C., Stanger, B. Z., Bardeesy, N. M., & DePinho, R. A. (2006) · Genes & Development · doi:10.1101/gad.1415606 · Cited by 1,570 · see citing works

Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice

Guerra, C., Schuhmacher, A. J., Cañamero, M., Grippo, P. J., Verdaguer, L., Pérez-Gallego, L., Dubus, P., Sandgren, E. P., & Barbacid, M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.01.012 · Cited by 1,224 · see citing works

Somatic activation of the K-ras oncogene causes early onset lung cancer in mice

Johnson, L., Mercer, K., Greenbaum, D., Bronson, R. T., Crowley, D., Tuveson, D. A., & Jacks, T. (2001) · Nature · doi:10.1038/35074129 · Cited by 1,179 · see citing works

LKB1 modulates lung cancer differentiation and metastasis

Ji, H., Ramsey, M. R., Hayes, D. N., Fan, C., McNamara, K., Kozlowski, P., Torrice, C., Wu, M. C., Shimamura, T., Perera, S. A., et al. (2007) · Nature · doi:10.1038/nature06030 · Cited by 1,064 · see citing works

Activated Kras and <i>Ink4a/Arf</i> deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma

Aguirre, A. J., Bardeesy, N., Sinha, M., Lopez, L., Tuveson, D. A., Horner, J., Redston, M. S., & DePinho, R. A. (2003) · Genes &amp; Development · doi:10.1101/gad.1158703 · Cited by 1,033 · cited 2× · see citing works

Ras in Cancer and Developmental Diseases

Fernández‐Medarde, A., & Santos, E. (2011) · Genes & Cancer · doi:10.1177/1947601911411084 · Cited by 959 · see citing works

The RASopathies

Rauen, K. A. (2013) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-091212-153523 · Cited by 877 · see citing works

Endogenous oncogenic K-rasG12D stimulates proliferation and widespread neoplastic and developmental defects

Tuveson, D. A., Shaw, A. T., Willis, N. A., Silver, D. P., Jackson, E. L., Chang, S., Mercer, K. L., Grochow, R., Hock, H., Crowley, D., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00085-6 · Cited by 798 · see citing works

Noonan syndrome

Roberts, A. E., Allanson, J. E., Tartaglia, M., & Gelb, B. D. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61023-x · Cited by 791 · see citing works

Germline KRAS mutations cause Noonan syndrome

Schubbert, S., Zenker, M., Rowe, S. L., Böll, S., Klein, C., Bollag, G., van der Burgt, I., Musante, L., Kalscheuer, V., Wehner, L.-E., et al. (2006) · Nature Genetics · doi:10.1038/ng1748 · Cited by 730 · see citing works

Pancreatic Cancer

Maitra, A., & Hruban, R. H. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.154305 · Cited by 707 · see citing works

Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context

Guerra, C. E., Mijimolle, N., Dhawahir, A., Dubus, P. R., Barradas, M., Serrano, M., Campuzano, V., & Barbacid, M. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00191-0 · Cited by 566 · see citing works

The Differential Effects of Mutant <i>p53</i> Alleles on Advanced Murine Lung Cancer

Jackson, E. L., Olive, K. P., Tuveson, D. A., Bronson, R., Crowley, D., Brown, M., & Jacks, T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2193 · Cited by 553 · see citing works

Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence

Guerra, C., Collado, M., Navas, C., Schuhmacher, A. J., Hernández-Porras, I., Cañamero, M., Rodriguez-Justo, M., Serrano, M., & Barbacid, M. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.05.011 · Cited by 516 · see citing works

Risk of pancreatic adenocarcinoma in chronic pancreatitis

Malka, D., Hammel, P. R., Maire, F., Rufat, P., Madeira, I., Pessione, F., Lévy, P., & Ruszniewski, P. B. (2002) · Gut · doi:10.1136/gut.51.6.849 · Cited by 456 · see citing works

Noonan syndrome and clinically related disorders

Tartaglia, M., Gelb, B. D., & Zenker, M. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.09.002 · Cited by 420 · see citing works

A Synthetic Lethal Interaction between K-Ras Oncogenes and Cdk4 Unveils a Therapeutic Strategy for Non-small Cell Lung Carcinoma

Puyol, M., Martín, A., Dubus, P., Mulero, F., Pizcueta, P., Khan, G., Guerra, C., Santamaría, D., & Barbacid, M. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.05.025 · Cited by 415 · see citing works

Gain-of-Function Mutations in RIT1 Cause Noonan Syndrome, a RAS/MAPK Pathway Syndrome

Aoki, Y., Niihori, T., Banjo, T., Okamoto, N., Mizuno, S., Kurosawa, K., Ogata, T., Takada, F., Yano, M., Ando, T., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.05.021 · Cited by 331 · see citing works

Wildtype Kras2 can inhibit lung carcinogenesis in mice

Zhang, Z., Wang, Y., Vikis, H. G., Johnson, L., Liu, G., Li, J., Anderson, M. W., Sills, R. C., Hong, H. L. T., Devereux, T. R., et al. (2001) · Nature Genetics · doi:10.1038/ng721 · Cited by 295 · see citing works

Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes

Kratz, C. P., Rapisuwon, S., Reed, H., Hasle, H., & Rosenberg, P. S. (2011) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.30300 · Cited by 221 · see citing works

Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes

Kratz, C. P., Franke, L., Peters, H., Kohlschmidt, N., Kazmierczak, B., Finckh, U., Bier, A., Eichhorn, B., Blank, C. U., Kraus, C. S., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.75 · Cited by 217 · see citing works

Tumor predisposition in Costello syndrome

Gripp, K. W. (2005) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.30065 · Cited by 193 · see citing works

HRAS mutations in Costello syndrome: Detection of constitutional activating mutations in codon 12 and 13 and loss of wild‐type allele in malignancy

Estep, A. L., Tidyman, W. E., Teitell, M. A., Cotter, P. D., & Rauen, K. A. (2005) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31078 · Cited by 180 · see citing works

Genetically engineered mouse models of pancreatic adenocarcinoma

Guerra, C. E., & Barbacid, M. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.02.002 · Cited by 179 · see citing works

Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation

Jongmans, M. C. J., van der Burgt, I., Hoogerbrugge, P. M., Noordam, C., Yntema, H. G., Nillesen, W. M., Kuiper, R. P., Ligtenberg, M. J. L., van Kessel, A. G., van Krieken, J. H., et al. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.37 · Cited by 178 · see citing works

Identification of cancer initiating cells in K-Ras driven lung adenocarcinoma

Mainardi, S., Mijimolle, N., Francoz, S., Vicente‐Dueñas, C., Sánchez-Garcı́a, I., & Barbacid, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320383110 · Cited by 165 · see citing works

Germline KRAS mutations cause aberrant biochemical and physical properties leading to developmental disorders

Gremer, L., Merbitz-Zahradnik, T., Dvorsky, R., Cirstea, I. C., Kratz, C. P., Zenker, M., Wittinghofer, A., & Ahmadian, M. R. (2011) · Human Mutation · doi:10.1002/humu.21377 · Cited by 158 · see citing works

Hematopoiesis and leukemogenesis in mice expressing oncogenic NrasG12D from the endogenous locus

Li, Q., Haigis, K. M., McDaniel, A., Harding-Theobald, E. R., Kogan, S. C., Akagi, K., Wong, J. C. Y., Braun, B. S., Wolff, L., Jacks, T., et al. (2010) · Blood · doi:10.1182/blood-2010-04-280750 · Cited by 154 · see citing works

Mouse models for lung cancer

Kwon, M.-C., & Berns, A. J. M. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.02.010 · Cited by 145 · see citing works

Activating mutations in RRAS underlie a phenotype within the RASopathy spectrum and contribute to leukaemogenesis

Flex, E., Jaiswal, M., Pantaleoni, F., Martinelli, S., Strullu, M., Fansa, E. K., Caye‐Eude, A., Luca, A. D., Lepri, F. R., Dvorský, R., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu148 · Cited by 145 · see citing works

Wild-Type H- and N-Ras Promote Mutant K-Ras-Driven Tumorigenesis by Modulating the DNA Damage Response

Grabocka, E., Pylayeva‐Gupta, Y., Jones, M. V., Lubkov, V., Yemanaberhan, E., Taylor, L. J., Jeng, H. H., & Bar‐Sagi, D. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.005 · Cited by 141 · see citing works

RAS diseases in children

Niemeyer, C. M. (2014) · Haematologica · doi:10.3324/haematol.2014.114595 · Cited by 140 · see citing works

Endogenous expression of Hras G12V induces developmental defects and neoplasms with copy number imbalances of the oncogene

Chen, X., Mitsutake, N., LaPerle, K., Akeno, N., ZANZONICO, P. B., Longo, V. A., Mitsutake, S., Kimura, E. T., Geiger, H., Santos, E., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900343106 · Cited by 139 · see citing works

A mouse model for Costello syndrome reveals an Ang II–mediated hypertensive condition

Schuhmacher, A. J., Guerra, C. E., Sauzeau, V., Cañamero, M., Bustelo, X. R., & Barbacid, M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34385 · Cited by 112 · see citing works

Autoimmune disease and multiple autoantibodies in 42 patients with RASopathies

Quaio, C. R. D. C., de Carvalho, J. F., Silva, C. A., Bueno, C., Brasil, A. S., Pereira, A. C., Jorge, A. A. L., Malaquias, A. C., Kim, C. A., & Bertola, D. R. (2012) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35290 · Cited by 99 · see citing works

Biochemical and Functional Characterization of Germ Line KRAS Mutations

Schubbert, S., Bollag, G. E., Lyubynska, N., Nguyen, H. T., Kratz, C. P., Zenker, M., Niemeyer, C. M., Molven, A., & Shannon, K. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00965-07 · Cited by 99 · see citing works

K-Ras ^V14I recapitulates Noonan syndrome in mice

Hernández-Porras, I., Fabbiano, S., Schuhmacher, A. J., Aicher, A., Cañamero, M., Cámara, J. A., Cussó, L., Desco, M., Heeschen, C., Mulero, F., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1418126111 · Cited by 96 · see citing works

Adenoviral Augmentation of Elafin Protects the Lung Against Acute Injury Mediated by Activated Neutrophils and Bacterial Infection

Simpson, A. J., Wallace, W. A., Marsden, M. E., Govan, J. R. W., Porteous, D. J., Haslett, C., & Sallenave, J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1778 · Cited by 89 · see citing works

LOH of chromosome 12p correlates with Kras2 mutation in non-small cell lung cancer

Li, J., Zhang, Z., Zunyan Dai, Y., Plass, C., Morris, Q., Wang, Y., Wiest, J. S., Anderson, M. W., & You, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206192 · Cited by 58 · see citing works

The N-ras proto-oncogene can suppress the malignant phenotype in the presence or absence of its oncogene.

Díaz, R., Ahn, D. H., Lopez-Barcons, L. A., Malumbres, M., de Castro, I. P., Lue, J., Ferrer‐Miralles, N., Mangues, R., Tsong, J., Garcia, R., et al. (2002) · PubMed · Cited by 50 · see citing works

Malignancy in Noonan syndrome and related disorders

Smpokou, P., Zand, D. J., Rosenbaum, K. N., & Summar, M. L. (2015) · Clinical Genetics · doi:10.1111/cge.12568 · Cited by 46 · see citing works

Noonan syndrome caused by germline KRAS mutation in Taiwan: report of two patients and a review of the literature

Lo, F., Lin, J., Kuo, M.-T., Chiu, P., Shu, S., Chao, M., Lee, Y., & Lin, S. (2008) · European Journal of Pediatrics · doi:10.1007/s00431-008-0858-z · Cited by 36 · see citing works

Noonan syndrome and systemic lupus erythematosus in a patient with a novel KRAS mutation.

Leventopoulos, G., Denayer, E., Makrythanasis, P., Papapolychroniou, C., & Fryssira, H. (2010) · PubMed · Cited by 29 · see citing works

The RASopathies: from pathogenetics to therapeutics

Hebron, K. E., Hernandez, E. R., & Yohe, M. E. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049107 · Cited by 167 · see citing works

Mutation-Induced Impacts on the Switch Transformations of the GDP- and GTP-Bound K-Ras: Insights from Multiple Replica Gaussian Accelerated Molecular Dynamics and Free Energy Analysis

Chen, J., Zhang, S., Wang, W., Pang, L., Zhang, Q., & Liu, X. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c01470 · Cited by 140 · see citing works

Classification of KRAS -Activating Mutations and the Implications for Therapeutic Intervention

Johnson, C. W., Burkhart, D. L., & Haigis, K. M. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0035 · Cited by 130 · see citing works

Assessment of mutation probabilities of KRAS G12 missense mutants and their long-timescale dynamics by atomistic molecular simulations and Markov state modeling

Pantsar, T., Rissanen, S., Dauch, D., Laitinen, T., Vattulainen, I., & Poso, A. (2018) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1006458 · Cited by 85 · see citing works

A Phase 2 Study of Capmatinib in Patients With MET-Altered Lung Cancer Previously Treated With a MET Inhibitor

Dagogo‐Jack, I., Moonsamy, P., Gainor, J. F., Lennerz, J. K., Piotrowska, Z., Lin, J. J., Lennes, I. T., Sequist, L. V. D., Shaw, A. T., Goodwin, K., et al. (2021) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2021.01.1605 · Cited by 63 · see citing works

A Recurrent De Novo Variant in NACC1 Causes a Syndrome Characterized by Infantile Epilepsy, Cataracts, and Profound Developmental Delay

Schoch, K., Meng, L., Szelinger, S., Bearden, D. R., Stray‐Pedersen, A., Busk, Ø. L., Stong, N., Liston, E., Cohn, R. D., Scaglia, F., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.12.013 · Cited by 48 · see citing works

New Noonan Syndrome Model Mice with RIT1 Mutation Exhibit Cardiac Hypertrophy and Susceptibility to β-adrenergic Stimulation-Induced Cardiac Fibrosis

Takahara, S., Inoue, S., Miyagawa‐Tomita, S., Matsuura, K., Nakashima, Y., Niihori, T., Matsubara, Y., Saiki, Y., & Aoki, Y. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2019.03.014 · Cited by 33 · see citing works

Structural basis of the atypical activation mechanism of KRASV14I

Bera, A. K., Lu, J., Wales, T. E., Gondi, S. R., Gurbani, D., Nelson, A., Engen, J. R., & Westover, K. D. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009131 · Cited by 30 · see citing works

Probing mutation-induced conformational transformation of the GTP/M-RAS complex through Gaussian accelerated molecular dynamics simulations

Bao, H., Wang, W., Sun, H., & Chen, J. (2023) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2023.2195995 · Cited by 26 · see citing works

Cluster analysis on conformational changes of the GDP/KRAS complex induced by A59G and D33E

Zhao, J., Wang, L., Bao, H., & Chen, J. (2021) · Chemical Physics Letters · doi:10.1016/j.cplett.2021.138995 · Cited by 10 · see citing works

Conformational States of the GDP- and GTP-Bound HRAS Affected by A59E and K117R: An Exploration from Gaussian Accelerated Molecular Dynamics

Yu, Z., Wang, Z., Cui, X., Cao, Z., Zhang, W., Sun, K., & Hu, G. (2024) · Molecules · doi:10.3390/molecules29030645 · Cited by 7 · see citing works

Noonan syndrome: lessons learned from genetically modified mouse models

Schuhmacher, A. J., Hernández-Porras, I., García-Medina, R., & Guerra, C. E. (2017) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2017.1361821 · Cited by 4 · see citing works

Proteomic Perspectives on KRAS-Driven Cancers and Emerging Therapeutic Approaches

Karki, R., Chen, R., & Pan, S. (2025) · Current Oncology · doi:10.3390/curroncol32110614 · Cited by 2 · see citing works

Modeling the Non-NF1 RASopathies

Insinna, C., & Yohe, M. E. (2024) · Springer eBooks · doi:10.1007/978-3-031-62945-7_40

Elucidating conformational dynamics of GDP/GTP-KRAS complexes caused by mutations from the switch domain I through Gaussian accelerated molecular dynamics simulations

Shi, S., Liu, A., & Guo, Y. (2026) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2025.2610685

TRAF7 mutations stabilize K/NRAS and hyperactivate MAPK signaling to cause CAFDADD neurodevelopmental defects

Xiao, M., Liu, Y., Song, X., Liu, J., Tang, X., Maosen, 窦. D., Yu, W., Zhang, H., Weng, W., Han, D., et al. (2026) · Science Advances · doi:10.1126/sciadv.adw8672

K-Ras ^V14I recapitulates Noonan syndrome in mice

Hernández-Porras, I., Fabbiano, S., Schuhmacher, A. J., Aicher, A., Cañamero, M., Cámara, J. A., Cussó, L., Desco, M., Heeschen, C., Mulero, F., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1418126111 · Cited by 96 · see citing works

The impact of the genetic background in the Noonan syndrome phenotype induced by K-RasV14I

Hern, I., Schuhmacherx, A. J., & Guerra, C. (2016)

Novel Germ Line Mutations in the KRAS2 Gene Cause Noonan Syndrome and Deregulate Hematopoietic Cell Growth.

Schubbert, S., Zenker, M., Rowe, S. L., Böll, S., Klein, C., van der Burgt, I., Musante, L., Nguyen, H. T., West, B. L., Bollag, G. E., et al. (2005) · Blood · doi:10.1182/blood.v106.11.1602.1602

Germline KRAS mutations cause Noonan syndrome

Schubbert, S., Zenker, M., Rowe, S. L., Böll, S., Klein, C., Bollag, G., van der Burgt, I., Musante, L., Kalscheuer, V., Wehner, L.-E., et al. (2006) · Nature Genetics · doi:10.1038/ng1748 · Cited by 730 · see citing works

Biochemical and Functional Analysis of Germline KRAS Mutations That Cause Disorders of the Noonan Syndrome Spectrum.

Schubbert, S., Sövik, O., Bollag, G. E., Nguyen, H. T., Rowe, S. L., Kratz, C. P., Zenker, M., Niemeyer, C. M., Molven, A., & Shannon, K. (2006) · Blood · doi:10.1182/blood.v108.11.1431.1431 · Cited by 2 · see citing works